GenMark Diagnostics to Present at the William Blair 38th Annual Growth Stock Conference
June 06 2018 - 8:00AM
GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of
automated, multiplex molecular diagnostic testing systems, today
announced that President and Chief Executive Officer, Hany
Massarany, will present at the William Blair 38th Annual Growth
Stock Conference in Chicago, IL.
Mr. Massarany is scheduled to present on Wednesday, June 13 at
10:40 a.m. Central Time. Interested parties may access a live
and archived webcast of the event at ir.genmarkdx.com.
ABOUT GENMARK DIAGNOSTICS GenMark
Diagnostics (NASDAQ:GNMK) is a leading provider of multiplex
molecular diagnostic solutions designed to enhance patient care,
improve key quality metrics, and reduce the total cost-of-care.
Utilizing GenMark's proprietary eSensor® detection technology,
GenMark's eSensor XT-8® and ePlex® systems are designed to support
a broad range of molecular diagnostic tests with compact,
easy-to-use workstations and self-contained, disposable test
cartridges. GenMark’s ePlex: The True Sample-to-Answer Solution™ is
designed to optimize laboratory efficiency and address a broad
range of infectious disease testing needs, including respiratory,
bloodstream, and gastrointestinal infections. For more
information, visit www.genmarkdx.com.
Investor Relations ContactLynn Pieper Lewis or
Leigh Salvo(415) 937-5404ir@genmarkdx.com
GenMark Diagnostics (NASDAQ:GNMK)
Historical Stock Chart
From Mar 2024 to Apr 2024
GenMark Diagnostics (NASDAQ:GNMK)
Historical Stock Chart
From Apr 2023 to Apr 2024